Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells

Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells

Abstract Background Nanocarriers have the potential to improve the therapeutic index of currently available drugs by increasing drug efficacy, lowering drug toxicity and achieving steady-state therapeutic levels of drugs over an extended period. The association of maghemite nanoparticles (NPs) with...

Full description

Bibliographic Details
Main Authors: Natalia Lemos Chaves, Danilo Aquino Amorim, Cláudio Afonso Pinho Lopes, Irina Estrela-Lopis, Julia Böttner, Aparecido Ribeiro de Souza, Sônia Nair Báo
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Cancer Nanotechnology
Subjects:
Maghemite
MCF-7
MDA-MB-231
Metastatic cells
Online Access:http://link.springer.com/article/10.1186/s12645-019-0052-1

Internet

http://link.springer.com/article/10.1186/s12645-019-0052-1

Similar Items